PL424214A1 - Test diagnostyczny do wykrywania zakażeń i/lub nosicielstwa Streptococcus agalactiae wykorzystujący wyselekcjonowane markery polipeptydowe - Google Patents

Test diagnostyczny do wykrywania zakażeń i/lub nosicielstwa Streptococcus agalactiae wykorzystujący wyselekcjonowane markery polipeptydowe

Info

Publication number
PL424214A1
PL424214A1 PL424214A PL42421418A PL424214A1 PL 424214 A1 PL424214 A1 PL 424214A1 PL 424214 A PL424214 A PL 424214A PL 42421418 A PL42421418 A PL 42421418A PL 424214 A1 PL424214 A1 PL 424214A1
Authority
PL
Poland
Prior art keywords
streptococcus agalactiae
infections
carrying
detection
diagnostic test
Prior art date
Application number
PL424214A
Other languages
English (en)
Other versions
PL239045B1 (pl
Inventor
Sabina GÓRSKA
Ewa BRZOZOWSKA
Andrzej Gamian
Monika BRZYCHCZY-WŁOCH
Anna DOBRUT
Original Assignee
Uniwersytet Jagielloński
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński, Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk filed Critical Uniwersytet Jagielloński
Priority to PL424214A priority Critical patent/PL239045B1/pl
Priority to EP19739066.9A priority patent/EP3737948A4/en
Priority to US16/960,844 priority patent/US12153047B2/en
Priority to PCT/PL2019/050002 priority patent/WO2019139494A1/en
Publication of PL424214A1 publication Critical patent/PL424214A1/pl
Publication of PL239045B1 publication Critical patent/PL239045B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem zgłoszenia jest białko zawierające sekwencje aminokwasową wybraną spośród: Sekw. Nr 1-2 oraz zawartych w nich epitopów. Niniejsze zgłoszenie obejmuje też epitop jego pochodną oraz sposób, który umożliwia potwierdzenie zakażeń/nosicielstwa wywołanych przez gatunek bakterii Streptococcus agalactiae. W sposobie wykorzystuje się specyficzną reakcję wyselekcjonowanych epitopów wchodzących w skład białek immunoreaktywnych izolatów klinicznych Streptococcus agalactiae z przeciwciałami obecnymi w surowicy.
PL424214A 2018-01-09 2018-01-09 Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae PL239045B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL424214A PL239045B1 (pl) 2018-01-09 2018-01-09 Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
EP19739066.9A EP3737948A4 (en) 2018-01-09 2019-01-09 DIAGNOSTIC TEST
US16/960,844 US12153047B2 (en) 2018-01-09 2019-01-09 Diagnostic test
PCT/PL2019/050002 WO2019139494A1 (en) 2018-01-09 2019-01-09 Diagnostic test

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL424214A PL239045B1 (pl) 2018-01-09 2018-01-09 Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae

Publications (2)

Publication Number Publication Date
PL424214A1 true PL424214A1 (pl) 2019-07-15
PL239045B1 PL239045B1 (pl) 2021-11-02

Family

ID=67209633

Family Applications (1)

Application Number Title Priority Date Filing Date
PL424214A PL239045B1 (pl) 2018-01-09 2018-01-09 Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae

Country Status (4)

Country Link
US (1) US12153047B2 (pl)
EP (1) EP3737948A4 (pl)
PL (1) PL239045B1 (pl)
WO (1) WO2019139494A1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
WO2014209142A1 (en) * 2013-06-28 2014-12-31 Uniwersytet Jagielloński A diagnostic test of streptococcus agalactiae infections
CN105861521A (zh) * 2016-05-13 2016-08-17 中山大学 罗非鱼源无乳链球菌重组GroEL蛋白疫苗的制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952395A (en) * 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
WO2001016174A2 (en) * 1999-08-30 2001-03-08 Rolf Kiessling Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65
GB0016063D0 (en) 2000-06-30 2000-08-23 Blc Leather Technology Centre Testing of leather
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
CA2591510A1 (en) * 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics, Inc. Group b streptococcus
JP5468299B2 (ja) 2009-05-15 2014-04-09 旭化成ファーマ株式会社 Ｉｍｐｄｈ含有組成物及びｉｍｐｄｈの安定化方法
EP4012714A1 (en) * 2010-03-23 2022-06-15 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
WO2014209142A1 (en) * 2013-06-28 2014-12-31 Uniwersytet Jagielloński A diagnostic test of streptococcus agalactiae infections
CN105861521A (zh) * 2016-05-13 2016-08-17 中山大学 罗非鱼源无乳链球菌重组GroEL蛋白疫苗的制备方法及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE UNIPROT, 60 KDA CHAPERONIN, 11 April 2003 (2003-04-11) *
DATABASE UNIPROT, INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE, 15 February 2017 (2017-02-15) *
K. FLUEGGE, IDENTIFICATION AND IMMUNOREACTIVITY OF PROTEINS RELEASED FROM STREPTOCOCCUS AGALACTIAE, 2004 *
MONIKA BRZYCHCZY-WLOCH, IDENTIFICATION OF HIGH IMMUNOREACTIVE PROTEINS FROM STREPTOCOCCUS AGALACTIAE ISOLATES RECOGNIZED BY HUMAN SERUM ANTIBODIES, 2013 *

Also Published As

Publication number Publication date
PL239045B1 (pl) 2021-11-02
EP3737948A1 (en) 2020-11-18
EP3737948A4 (en) 2022-06-01
WO2019139494A1 (en) 2019-07-18
US12153047B2 (en) 2024-11-26
US20210033607A1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
DK2780717T3 (en) ADRENOMEDULLINASSAYS AND METHODS FOR DETERMINING MODERN ADRENOMEDULLIN
EA202090247A1 (ru) Антитела против cd166 и их применения
BR112018070823A2 (pt) anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno.
RU2015104579A (ru) Диагностические анализы и наборы для детекции фолатного рецептора 1
CA3047691C (en) Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
BR112015008036A2 (pt) população de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica e kit
CY1125342T1 (el) Μεθοδοι για την ανιχνευση και/ή μετρηση αντισωματων εναντι των αντισωματων φαρμακου, ιδιως αντισωματων εναντι των αντισωματων φαρμακου προκυπτοντων κατα τη θεραπευτικη αγωγη
CN104792997A (zh) 一种人降钙素原免疫检测试剂盒及其制备方法与应用
EP4534972A3 (en) Synthetic controls for immunohistochemistry
RU2017114626A (ru) Антитело, связывающее линейный эпитоп человеческого р53, и его применение в диагностике
KR102431142B1 (ko) L-fabp의 면역학적 측정 방법 및 해당 방법에 사용되는 측정 시약
Uzcanga et al. Serodiagnosis of bovine trypanosomosis caused by non-tsetse transmitted Trypanosoma (Duttonella) vivax parasites using the soluble form of a Trypanozoon variant surface glycoprotein antigen
EP3919509B1 (en) Method for immunological analysis of free aim in biological sample
CN106153935A (zh) 一种定量检测CD79α的酶联免疫试剂盒
CN104931690A (zh) 一种pd-1抗体检测试剂盒及其应用
EP3537152A1 (en) Immunoassay method for determining renin concentration
PL424214A1 (pl) Test diagnostyczny do wykrywania zakażeń i/lub nosicielstwa Streptococcus agalactiae wykorzystujący wyselekcjonowane markery polipeptydowe
KR20250165646A (ko) Nr1에 대한 자가항체의 검출
CN107857815B (zh) 与糖肽反应的单克隆抗体及其用途
Amini et al. Production and characterization of polyclonal antibody against a synthetic peptide from β-actin protein
MX2022005611A (es) Peptidos antigenicos de enolasa especificos de neuronas para el diagnostico y el tratamiento del autismo.
US9201070B2 (en) Antigenic structure and uses thereof for screening trypanosomiases in humans and animals
KR102094727B1 (ko) 인플루엔자 바이러스의 헤마글루티닌 측정 방법
PL404498A1 (pl) Test diagnostyczny zakażeń Streptococcus agalactiae